from – RNAi News
NIH has awarded millions to support microRNA research under the American Recovery and Reinvestment Act. Two of the largest grants went to Dr. Sohail Tavazoie at the Rockefeller University and Dr. Carlo Croce at the Ohio State University. Tavazoie studies miRNAs that can be used to predict how a cancer patient will respond to chemotherapy, focusing on colorectal cancer, and Croce studies how the loss of one specific miRNA can be used to predict how a patient will repond to demethylating agents. (read more)



